Funded Tech Companies
MyoKardia
Wondering who provided funding to MyoKardia? Sanofi-Genzyme BioVentures, private investors and Casdin Capital put venture money into this innovative biopharmaceutical company.
Company Overview
Company Name
MyoKardia
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1000 Sierra Point Pkwy.
Brisbane, CA 94005
USA
Brisbane, CA 94005
USA
Phone
Website
Email Address
Company Background Information
Overview
MyoKardia is dedicated to revolutionizing the treatment of cardiovascular disease. The company's first programs include hypertrophic and dilated cardiomyopathy (HCM and DCM), which together afflict approximately 1 million people in the United States, and for which no novel therapeutics have been brought to market in over a decade.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/28/2015
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tassos Gianakakos
Chief Financial Officer
Taylor Harris
Chief Medical Officer
Marc Semigran
Chief Scientific Officer
Robert McDowell
VP - Bus. Development
Jake Bauer
VP - Human Resources
Ingrid Boyes
Company Investors
- Sanofi-Genzyme BioVentures
- Casdin Capital
- Cormorant Asset Management
- Perceptive Advisors
- Third Rock Ventures (Charles Homcy)
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
The company data above is provided by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs